Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study.
Department of Neurology and Clinical Neurophysiology, Munich-Harlaching Clinic, Germany.
In order to evaluate the prophylactic effect of oral magnesium, 81 patients aged 18-65 years with migraine according to the International Headache Society (IHS) criteria (mean attack frequency 3.6 per month) were examined. After a prospective baseline period of 4 weeks they received oral 600 mg (24 mmol) magnesium (trimagnesium dicitrate) daily for 12 weeks or placebo. In weeks 9-12 the attack frequency was reduced by 41.6% in the magnesium group and by 15.8% in the placebo group compared to the baseline (p < 0.05). The number of days with migraine and the drug consumption for symptomatic treatment per patient also decreased significantly in the magnesium group. Duration and intensity of the attacks and the drug consumption per attack also tended to decrease compared to placebo but failed to be significant. Adverse events were diarrhea (18.6%) and gastric irritation (4.7%). High-dose oral magnesium appears to be effective in migraine prophylaxis.
Headache. 2004 Oct;44(9):885-90.
A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial. Maizels M, Blumenfeld A, Burchette R.
J Am Acad Nurse Pract. 2004 Jun;16(6):251-6.
Evidenced-based use of botanicals, minerals, and vitamins in the prophylactic treatment of migraines. Rios J, Passe MM.
Eur J Neurol. 2004 Jul;11(7):475-7.
High-dose riboflavin treatment is efficacious in migraine prophylaxis: an open study in a tertiary care centre. Boehnke C, Reuter U, Flach U, Schuh-Hofer S, Einhaupl KM, Arnold G.
Intern Med J. 2004 Jun;34(6):372-3;
author reply 373. Comment on: Intern Med J. 2003 Sep-Oct;33(9-10):436-42. High-dose riboflavin for the prevention of migraine: can we afford to ignore it? Davis JS.
Vitam Horm. 2004;69:297-312.
Role of magnesium, coenzyme Q10, riboflavin, and vitamin B12 in migraine prophylaxis. Bianchi A, Salomone S, Caraci F, Pizza V, Bernardini R, D’Amato CC. Department of Pharmaceutical Sciences, University of Salerno, 84084 Fisciano, Italy
Neurology. 1998 Feb;50(2):466-70.
Comment in: ACP J Club. 1998 Sep-Oct;129(2):33. Can Fam Physician. 2003 Oct;49:1291-3. Neurology. 1999 Jan 15;52(2):431-2. Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial. Schoenen J, Jacquy J, Lenaerts M. Department of Neurology, University of Liege, CHR Citadelle, Belgium.